Doximity is trading 4.89% down now at $25.06, after declining from the September 7 close of $26.35; the catalyst remains unclear.
- No credible company-specific announcement, earnings release, or analyst action dated September 8, 2026, was identified.
- Broader pre-market sentiment is cautious, but major indices do not show a sufficiently aligned decline to explain the full move.
- The catalyst should be rechecked for delayed company news.